HOLX News and Press, Hologic Inc. From 04/27/22

Image source: The Motley Fool. Hologic (NASDAQ: HOLX) Q2 2022 Earnings Call Apr 27, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Hologic (HOLX) Q2 2022 Earnings Call Transcript

Hologic press release (NASDAQ:HOLX): FQ2 Non-GAAP EPS of $2.07 beats by $0.47. Revenue of $1.44B (-6.5% Y/Y) beats by $150M. 3Q22 revenue to be in the range of $875M to $915M vs. consensus of $878.1M and adjusted EPS of $0.67 to $0.72 vs. consensus of $0.67. For further details see: Hol...

– Revenue of $1.436 Billion, GAAP Diluted EPS of $1.80, and Non-GAAP Diluted EPS of $2.07 All Significantly Ahead of Expectations – – Company Again Increases Full-Year Revenue and EPS Guidance – Hologic, Inc. (Nasdaq: HOLX) announced today the Com...

Wells Fargo has downgraded life sciences company Thermo Fisher Scientific (NYSE:TMO) to underweight and lowered the price target from $605 to $525, citing an expensive valuation and "material headwinds for the stock ahead". Thermo Fisher (TMO) is trading -4.37% currently and -1...

Guideline inclusion further validates the need to incorporate Breast Cancer Index into standard of care Hologic, Inc. (Nasdaq: HOLX) announced today that the American Society of Clinical Oncology (ASCO) has published an update which expands the utility of Breast Cancer Index...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy underperformed during a pronounced rotation ...

Pharmaceuticals and biotechnology still are attractive regarding value and quality. Other subsectors are overvalued by 15% to 42% relative to 11-year averages. Fast facts on IBB. 10 healthcare stocks cheaper than their peers in April. For further details see: IBB: He...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2022 on Wednesday, April 27, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Easte...

--The state-of-the-art facility in Aix-en-Provence also serves as the new headquarters of Hologic France-- Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, opened its new Innovation Center today in A...